Research on establishment of evaluation method and clinical usefulness of hyperarousal in the prevention of insomnia and mood disorders
Project/Area Number |
16K17353
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Clinical psychology
|
Research Institution | National Center of Neurology and Psychiatry |
Principal Investigator |
AYABE Naoko 国立研究開発法人国立精神・神経医療研究センター, 精神保健研究所 睡眠・覚醒障害研究部, 流動研究員 (50754769)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2018: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 不眠症 / 気分障害 / 過覚醒 / 認知行動療法 / 睡眠 / 不眠障害 |
Outline of Final Research Achievements |
The self-reported Hyperarousal Scale (HAS) can be used to assess the level of cognitive-emotional hyperarousal that underlies conditions such as insomnia and mood disorders The purpose of this study was to examine whether the hyperarousal state, evaluated using the HAS-Japanese version, is useful as a screening tool for insomnia and mood disorders. First, this study found insomnia patients had significantly higher scores than community dwellers. On the other hand, HAS score was still significantly higher in insomnia patients with alleviation of insomnia than in good sleepers. Furthermore, it has been shown that those with high hyperarousal scores, even if they are not depressed, are at risk of developing depressive symptoms one year later.
|
Academic Significance and Societal Importance of the Research Achievements |
HAS日本語版を用いて評価された過覚醒状態の高さは不眠症や抑うつの再発や発症のリスク因子となることが示唆された。従来の症状評価に過覚醒状態の評価を加えることで、不眠症や気分障害のハイリスク群のアセスメントに有用なスクリーニングツールとなる可能性が考えられる。また、予防的介入の観点のみならず、介入技法の選定や再発防止の観点からも有用な利用が期待される。
|
Report
(4 results)
Research Products
(16 results)
-
-
[Journal Article] Effectiveness of cognitive behavioral therapy for pharmacotherapy-resistant chronic insomnia: A multi-center randomized controlled trial in Japan2018
Author(s)
Ayabe, N., Okajima, I., Nakajima, S., Inoue, Y., Watanabe, N., Yamadera, W., Uchiyama, N., Tachimori, H., Kamei, Y., & Mishima, K.
-
Journal Title
Sleep Medicine
Volume: 50
Pages: 105-112
DOI
Related Report
Peer Reviewed
-
-
-
[Presentation] Effectiveness of cognitive behavioural therapy for insomnia: The tapering rate of hypnotics, sleep quality, and depression.2018
Author(s)
Ayabe, N., Okajima, I., Nakajima, S., Inoue, Y., Watanabe, N., Yamadera, W., Uchimura, N., Tachimori, H., Kamei, Y., Mishima, K.
Organizer
48th Annual Congress of the European Association for Behavioural and Cognitive Therapies
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-